K
Kim A. Eagle
Researcher at University of Michigan
Publications - 852
Citations - 85694
Kim A. Eagle is an academic researcher from University of Michigan. The author has contributed to research in topics: Aortic dissection & Myocardial infarction. The author has an hindex of 129, co-authored 823 publications receiving 75160 citations. Previous affiliations of Kim A. Eagle include University of Wisconsin Hospital and Clinics & Spaulding Rehabilitation Hospital.
Papers
More filters
Journal ArticleDOI
Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation.
Rajendra H. Mehta,Omar H. Dabbous,Christopher B. Granger,Polina Kuznetsova,Eva Kline-Rogers,Frederick A. Anderson,Keith A.A. Fox,Joel M. Gore,Robert J. Goldberg,Kim A. Eagle +9 more
TL;DR: Compared with patients with ACS without any AF, previous and new-onset AF are associated with increased hospital morbidity and mortality, however, only new-ONSet AF is an independent predictor of in-hospital adverse events in patients with ACS.
Journal ArticleDOI
A systematic review of gender differences in mortality after coronary artery bypass graft surgery and percutaneous coronary interventions.
TL;DR: The majority of studies noted greater in‐hospital mortality in women than in men, with mortality differences resolving with longer follow-up, and gender was an independent risk factor for complications after both CABG and PCI.
Journal ArticleDOI
Clinical and hemodynamic comparison of VVI versus DDD pacing in patients with DDD pacemakers.
TL;DR: To identify better those subgroups of pacemaker recipients who will benefit from dual chamber pacing, 19 patients with DDD pacemakers that were physiologically paced were entered into a blinded, randomized protocol comparing long-term VVI versus DDD pacing.
Journal ArticleDOI
Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality.
Peter K. Henke,Susan Blackburn,Mary C. Proctor,Jeri Stevens,Debabrata Mukherjee,Sanjay Rajagopalin,Gilbert R. Upchurch,James C. Stanley,Kim A. Eagle +8 more
TL;DR: Patients undergoing infrainguinal bypass are undertreated with respect to cardioprotective medications, and statin drug use is associated with improved graft patency and limb salvage.
Journal ArticleDOI
Reperfusion strategies in acute ST-segment elevation myocardial infarction: a comprehensive review of contemporary management options.
TL;DR: The emerging modality of pharmacoinvasive therapy, although controversial, seeks to combine the benefits of mechanical and pharmacologic reperfusion, and results from ongoing clinical trials will provide guidance regarding the utility of this strategy.